Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A large Canadian study found that just 2% of such women developed more severe cirrhosis within one year of delivery.
An analysis of hepatitis B testing among women of childbearing age found a declining national rate but increases in several states.
The CDC has called for treatment of opioid use disorder to include screening for hepatitis C and referral to care and treatment.
Inflammation in people with HIV is associated with cardiovascular disease and other serious health conditions.
#SHAAD debuts Tuesday, August 20. Here’s how you can be part of the Southern Solution.
The opioid epidemic has caused an increase in the incidence of hepatitis C among women of childbearing age, Is hope on the horizon?
This finding follows a recent study indicating that syphilis is on the rise among heterosexual people who inject drugs.
The U.S. Preventive Services Task Force has reaffirmed its 2009 recommendation.
Researchers analyzed the immunological mechanisms that may drive this difference.
Baby boomers still make up the largest bloc of those with the virus, but youths’ injection drug use is sending their infection rates upward.
A recent analysis of data from a roster of clinical trials yielded reassuring findings for this group of women who have hepatitis C.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
Please join the National Viral Hepatitis Roundtable for a webinar on December 13 on the topic of hepatitis C among pregnant women.
Unfortunately, no hepatitis C treatment is approved for use among expectant mothers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.